159 related articles for article (PubMed ID: 25641222)
1. Expression of vitamin D receptor as a potential prognostic factor and therapeutic target in pancreatic cancer.
Wang K; Dong M; Sheng W; Liu Q; Yu D; Dong Q; Li Q; Wang J
Histopathology; 2015 Sep; 67(3):386-97. PubMed ID: 25641222
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number.
Albrechtsson E; Jonsson T; Möller S; Höglund M; Ohlsson B; Axelson J
Pancreatology; 2003; 3(1):41-6. PubMed ID: 12649563
[TBL] [Abstract][Full Text] [Related]
3. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
4. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness.
Li Z; Jia Z; Gao Y; Xie D; Wei D; Cui J; Mishra L; Huang S; Zhang Y; Xie K
Clin Cancer Res; 2015 Feb; 21(4):844-53. PubMed ID: 25501129
[TBL] [Abstract][Full Text] [Related]
5. Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis.
Al-Azhri J; Zhang Y; Bshara W; Zirpoli G; McCann SE; Khoury T; Morrison CD; Edge SB; Ambrosone CB; Yao S
Clin Cancer Res; 2017 Jan; 23(1):97-103. PubMed ID: 27407090
[TBL] [Abstract][Full Text] [Related]
6. Alterations in vitamin D signaling pathway in gastric cancer progression: a study of vitamin D receptor expression in human normal, premalignant, and malignant gastric tissue.
Wen Y; Da M; Zhang Y; Peng L; Yao J; Duan Y
Int J Clin Exp Pathol; 2015; 8(10):13176-84. PubMed ID: 26722516
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics.
Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Wongkham S
Cancer; 2007 Jun; 109(12):2497-505. PubMed ID: 17487855
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.
Sherman MH; Yu RT; Engle DD; Ding N; Atkins AR; Tiriac H; Collisson EA; Connor F; Van Dyke T; Kozlov S; Martin P; Tseng TW; Dawson DW; Donahue TR; Masamune A; Shimosegawa T; Apte MV; Wilson JS; Ng B; Lau SL; Gunton JE; Wahl GM; Hunter T; Drebin JA; O'Dwyer PJ; Liddle C; Tuveson DA; Downes M; Evans RM
Cell; 2014 Sep; 159(1):80-93. PubMed ID: 25259922
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D Receptor Activation and Photodynamic Priming Enables Durable Low-dose Chemotherapy.
Anbil S; Pigula M; Huang HC; Mallidi S; Broekgaarden M; Baglo Y; De Silva P; Simeone DM; Mino-Kenudson M; Maytin EV; Rizvi I; Hasan T
Mol Cancer Ther; 2020 Jun; 19(6):1308-1319. PubMed ID: 32220968
[TBL] [Abstract][Full Text] [Related]
10. Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression.
Wei D; Wang L; Liu Y; Hafley MA; Tan L; Lorenzi PL; Yang P; Zuo X; Bresalier RS
Dig Dis Sci; 2023 Jul; 68(7):3043-3058. PubMed ID: 37071246
[TBL] [Abstract][Full Text] [Related]
11. Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.
Tsutsumi K; Sato N; Tanabe R; Mizumoto K; Morimatsu K; Kayashima T; Fujita H; Ohuchida K; Ohtsuka T; Takahata S; Nakamura M; Tanaka M
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S491-9. PubMed ID: 21837532
[TBL] [Abstract][Full Text] [Related]
12. Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis.
Yamahatsu K; Matsuda Y; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2012 May; 40(5):1345-57. PubMed ID: 22246533
[TBL] [Abstract][Full Text] [Related]
13. Decreased circadian component Bmal1 predicts tumor progression and poor prognosis in human pancreatic ductal adenocarcinoma.
Li W; Liu L; Liu D; Jin S; Yang Y; Tang W; Gong L
Biochem Biophys Res Commun; 2016 Mar; 472(1):156-62. PubMed ID: 26915801
[TBL] [Abstract][Full Text] [Related]
14. The clinicopathological significance and relationship of Gli1, MDM2 and p53 expression in resectable pancreatic cancer.
Sheng W; Dong M; Zhou J; Li X; Liu Q; Dong Q; Li F
Histopathology; 2014 Mar; 64(4):523-35. PubMed ID: 24289472
[TBL] [Abstract][Full Text] [Related]
15. Physiological and clinically attainable concentrations of 1,25-dihydroxyvitamin D3 suppress proliferation and extracellular matrix protein expression in mouse pancreatic stellate cells.
Bläuer M; Sand J; Laukkarinen J
Pancreatology; 2015; 15(4):366-71. PubMed ID: 26005021
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma.
Xia JT; Wang H; Liang LJ; Peng BG; Wu ZF; Chen LZ; Xue L; Li Z; Li W
Pancreas; 2012 May; 41(4):629-35. PubMed ID: 22249132
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor expression in invasive breast tumors and breast cancer survival.
Huss L; Butt ST; Borgquist S; Elebro K; Sandsveden M; Rosendahl A; Manjer J
Breast Cancer Res; 2019 Jul; 21(1):84. PubMed ID: 31358030
[TBL] [Abstract][Full Text] [Related]
18. TM4SF1 as a prognostic marker of pancreatic ductal adenocarcinoma is involved in migration and invasion of cancer cells.
Zheng B; Ohuchida K; Cui L; Zhao M; Shindo K; Fujiwara K; Manabe T; Torata N; Moriyama T; Miyasaka Y; Ohtsuka T; Takahata S; Mizumoto K; Oda Y; Tanaka M
Int J Oncol; 2015 Aug; 47(2):490-8. PubMed ID: 26035794
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of vitamin D receptor and insulin-like growth factor receptor 1 expression in triple-negative breast cancer.
Soljic M; Mrklic I; Tomic S; Omrcen T; Sutalo N; Bevanda M; Vrdoljak E
J Clin Pathol; 2018 Jan; 71(1):34-39. PubMed ID: 28663327
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
